These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30853326)

  • 1. Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
    Cannon E; Buechler S
    Clin Colorectal Cancer; 2019 Jun; 18(2):149-158. PubMed ID: 30853326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas.
    Kalady MF; Sanchez JA; Manilich E; Hammel J; Casey G; Church JM
    Dis Colon Rectum; 2009 Jun; 52(6):1039-45. PubMed ID: 19581844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
    Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
    Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of colon and rectal somatic DNA alterations.
    Slattery ML; Curtin K; Wolff RK; Boucher KM; Sweeney C; Edwards S; Caan BJ; Samowitz W
    Dis Colon Rectum; 2009 Jul; 52(7):1304-11. PubMed ID: 19571709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.
    Ferracin M; Gafà R; Miotto E; Veronese A; Pultrone C; Sabbioni S; Lanza G; Negrini M
    J Pathol; 2008 Apr; 214(5):594-602. PubMed ID: 18241079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML
    J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
    Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
    Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
    Ren Z; Wang W; Li J
    Int J Oncol; 2016 Feb; 48(2):690-702. PubMed ID: 26647925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    Reynolds IS; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Furney SJ; Burke JP
    J Surg Oncol; 2019 Dec; 120(8):1427-1435. PubMed ID: 31729037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation.
    Pancione M; Di Blasi A; Sabatino L; Fucci A; Dalena AM; Palombi N; Carotenuto P; Aquino G; Daniele B; Normanno N; Colantuoni V
    Hum Pathol; 2011 Jul; 42(7):1047-52. PubMed ID: 21315413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
    Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Changing Spectrum of Colorectal Cancer Biology With Age: Implications for the Young Patient.
    Chouhan H; Ferrandon S; DeVecchio J; Kalady MF; Church JM
    Dis Colon Rectum; 2019 Jan; 62(1):21-26. PubMed ID: 30394984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
    Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
    Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
    Li X; Wen D; Li X; Yao C; Chong W; Chen H
    Front Immunol; 2020; 11():1678. PubMed ID: 33013820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.